Changes in serial magnetic resonance spectroscopy predict outcome in high-grade glioma during and after postoperative radiotherapy

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3559-3565

  Quon, Harvey ^a   Brunet, Bryan ^a   Alexander, Abraham ^a   Murtha, Albert ^a   Abdulkarim, Bassam ^a   Fulton, Dorcas ^a   Smerdely, Marie ^a   Johnson, Maryann ^a   Urtasun, Raul ^a   Patel, Samir ^a   Ghosh, Sunita ^a   Roa, Wilson ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Brain neoplasms; Magnetic resonance spectroscopy; Prognosis; Prospective studies; Radiotherapy

Indexed keywords

CHOLINE; CREATININE; LOMUSTINE; N ACETYLASPARTIC ACID; TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GLIOMA; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; TREATMENT OUTCOME;

AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80054757867     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Central Brain Tumor Registry of the United S. Statistical report: Primary brain tumors in the United States, 1998-2002. 2005 Contract No.: Report.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for R, Treatment of Cancer Brain T, Radiotherapy G, National Cancer Institute of Canada Clinical Trials G. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine 352(10): 987-996, 2005.
3. Steen RG, Koury BSM, Granja CI, Xiong X, Wu S, Glass JO, Mulhem RK, Kun LE and Merchant TE: Effect of ionizing radiation on the human brain: White matter and gray matter t1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys 49(1): 79-91, 2001. (Pubitemid 32041279)
4. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG and Lev MH: Radiation necrosis versus glioma recurrence: Conventional mr imaging clues to diagnosis. AJNR American Journal of Neuroradiology 26(8): 1967-1972, 2005.
5. Vos MJ, Uitdehaag BM, Barkhof F, Heimans JJ, Baayen HC, Boogerd W, Castelijns JA, Elkhuizen PH and Postma TJ: Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology 60(5): 826-830, 2003. (Pubitemid 36297368)
6. Byrne TN: Imaging of gliomas. Semin Oncol 21(2): 162-171, 1994.
7. Kaplan RS: Complexities, pitfalls, and strategies for evaluating brain tumor therapies. Curr Opin Oncol 10(3): 175-178, 1998.
8. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP and Nelson SJ: 3d mrsi for resected high-grade gliomas before it: Tumor extent according to metabolic activity in relation to mri. Int J Radiat Oncol Biol Phys 59(1): 126-137, 2004. (Pubitemid 38501516)
9. Graves EE, Nelson SJ, Vigneron DB, Verhey L, McDermott M, Larson D, Chang S, Prados MD and Dillon WP: Serial proton mr spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR American Journal of Neuroradiology 22(4): 613-624, 2001. (Pubitemid 32318685)
10. Maheshwari SR, Fatterpekar GM, Castillo M and Mukherji SK: Proton mr spectroscopy of the brain. Seminars in ultrasound, CT, and MR 21(6): 434-451, 2000.
11. Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D and Jenden DJ: In vivo 1h mrs choline: Correlation with in vitro chemistry/histology. Life Sei 58(22): 1929-1935, 1996.
12. Ikehira H, Miyamoto T, Yasukawa T, Obata T, Katoh H, Koga M, Yoshikawa K, Yoshida K and Tateno Y: Differences in metabolic and morphological reactions after radiation therapy: Proton nmr spectroscopy and imaging of patients with intracranial tumors. Radiat Med 13(5): 199-204, 1995.
13. Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S and McKnight TR: Longitudinal multivoxel mr spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 62(7): 20-31, 2005. (Pubitemid 40591919)
14. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ and Curran WJ Jr.: Validation and predictive power of radiation therapy oncology group (rtog) recursive partitioning analysis classes for malignant glioma patients: A report using rtog 90-06. Int J Radiat Oncol Biol Phys 40(1): 51-55, 1998. (Pubitemid 28027566)
15. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M and Cloughesy T: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27(28): 4733-4740, 2009.
16. Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS and Fine HA: Phase ii trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27(5): 740-745, 2009.
17. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA and Griffiths JR: Metabolic profiles of human brain tumors using quantitative in vivo 1h magnetic resonance spectroscopy. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 49(2): 223-232, 2003.
18. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R and Arnold DL: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2(3): 323-325, 1996. (Pubitemid 26080653)
19. Rutkowski T, Tarnawski R, Sokol M and Maciejewski B: 1h-mr spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys 56(5): 1381-1389, 2003. (Pubitemid 36842891)
20. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE and Levin VA: Malignant gliomas: Mr imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217(2): 377-384, 2000.
21. Lazareff JA, Gupta RK and Alger J: Variation of post-treatment h-mrsi choline intensity in pediatric gliomas. J Neurooncol 41(3): 291-298, 1999. (Pubitemid 29209818)
22. Heesters MA, Kamman RL, Mooyaart EL and Go KG: Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. J Neurooncol 17(1): 27-35, 1993. (Pubitemid 24006746)
23. Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH and Vigneron DB: Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 87(4): 525-534, 1997. (Pubitemid 27430398)
24. Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach MO and Dzik-Jurasz AS: Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy. Br J Cancer 90(4): 781-786, 2004. (Pubitemid 38406586)
25. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR and Di Chiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87(4): 516-524, 1997. (Pubitemid 27430397)
26. Miller BL: A review of chemical issues in 1h nmr spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4(2): 47-52, 1991.
27. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R and Friedmann G: Human brain tumors: Spectral patterns detected with localized h-1 mr spectroscopy. Radiology 183(3): 701-709, 1992.
28. Sijens PE, Heesters MA, Enting RH, van der Graaf WT, Potze JH, Irwan R, Meiners LC and Oudkerk M: Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. Cancer Invest 25(8): 706-710, 2007. (Pubitemid 350223174)
29. Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L and Krupska T: 1h-mrs in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 52(5): 1271-1276, 2002. (Pubitemid 34302880)
30. Scott JG, Suh JH, Elson P, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H and Chao ST: Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: A retrospective review of 206 cases. Neuro Oncol 13(4): 428-436, 2011.
31. Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr. and Mehta MP: Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys 2010. [Epub ahead of print]